Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Estone Science and Technology Development is a Chinese biotechnology company focused on the development of high-precision molecular diagnostic systems. The company specializes in digital PCR (dPCR) technology, having developed the proprietary e-Drop platform which enables absolute quantification of nucleic acids with high sensitivity. Their product line includes automated dPCR instruments and a variety of diagnostic kits targeting oncology biomarkers, infectious diseases, and prenatal screening. Estone's solutions are primarily used for liquid biopsy, monitoring minimal residual disease, and companion diagnostics in clinical settings. By integrating microfluidics and advanced imaging, the company aims to provide accessible and accurate tools for precision medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Estone Science and Technology Development.